New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers' and pharmacy benefit managers' (PBMs) policies against covered entities and N.Y. pharmacies based on their 340B participation.
New York Unlikely to Move 340B Contract Pharmacy, PBM Protections Bill in 2024, Sponsors Say